New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review - Filippos Panteleimon Chatzipieris; Athanasios Kokkalis; Nikitas Georgiou; Errikos Petsas; Ektoras Vasileios Apostolou; Georgios C. Vougioukalakis; Thomas Mavromoustakos (ACS Omega)